# Sarepta Therapeutics, Inc.: Form 8-K, filed Jun 9, 2023

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2023-06-09
- Accepted by EDGAR: Jun 9, 2023, 16:29 ET
- Period: 2023-06-08
- Accession: 0000950170-23-027276
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000095017023027276/srpt-20230608.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000095017023027276/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000095017023027276/srpt-20230608.htm

Filed Jun 9, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-027276. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.